Binge eating disorder (BED) affects millions of Americans, yet treatment options remain limited
Until FDA approval, our priority remains offering patients safe, effective, accessible weight-loss solutions that work today. Other Non-Surgical Weight-Loss Options (Available NOW at Florida Surgery & Weight Loss) Tirzepatide (Mounjaro, Zepbound) Semaglutide (Ozempic, Wegovy) Compounded GLP-1/GIP peptides (where legally eligible) Nutritional planning & coaching Medical weight-loss evaluation Post-weight-loss surgery (Panniculectomy) options The medication does not walk the path for the patient
Hims uses asynchronous provider review
During clinical trials, for example, the most commonly noted side effects of Ozempic were gastrointestinal (GI) related and included nausea, vomiting, and diarrhea
The FDA does not certify or approve dietary supplements, so any marketing suggesting FDA endorsement for this product is inherently misleading